EVERSANA to participate at ISPOR Copenhagen

Analyze, Deliver, Measure and Communicate Value at Every Stage of the Product Lifecycle.

Meet us at ISPOR Copenhagen, November 2-6, 2019

Booth # C3-057

EVERSANA proudly announces our participation at ISPOR Copenhagen, taking place from November 2-6. ISPOR is the leading global conference for Health Economics and Outcomes Research. This year’s conference theme – Digital Transformation of Healthcare: Changing Roles and Sharing Responsibilities.

Meet our team of experts to learn more about EVERSANA’s patient-centric business model that brings together Value, Evidence, Market Access Insights, and Pricing to achieve commercial success for our clients.


Join our experts LIVE during one of the 17 presentations to get a deeper understanding of key issues driving our value-driven healthcare environment.

 

ISPOR EUROPE 2019

POSTER PRESENTATION SCHEDULE

PL = Poster Location

RPS=Research Poster Session

PDH = Poster Display Hour

ADH = Author Discussion Hour


RESEARCH POSTER SESSION 1 – MONDAY NOVEMBER 4

COST PER RESPONDER ANALYSIS OF GUSELKUMAB VERSUS SECUKINUMAB IN THE TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS BASED ON THE ECLIPSE TRIAL
Authors Druchok C, Pepper AN, Garside J, Hassan F
Poster # PSY12, PL V22 – PDH 10:30-14:00, ADH 13:00-14:00

INDIRECT COST BURDEN OF MODERATE-TO-SEVERE PSORIASIS IN EU5 AND THE SAVINGS GENERATED BY CHOOSING GUSELKUMAB OVER ADALIMUMAB
Authors Schubert A, Villacorta R, Davila J, Cordon A, Afonso N
Poster # PSY7, PL V17 – 
PDH 10:30-14:00, ADH 13:00-14:00

AN EXAMINATION OF THE BURDEN OF SICKLE CELL DISEASE AMONG ADULTS IN ENGLAND
Authors Morgan, G., Burke, T., Herquelot, E., Lamarsalle, L., Brown, S., Bonner, A., Bailey, M., Disher, T., Abioye, A.
Poster # PSY27, PL W24 –
PDH 10:30-14:00, ADH 13:00-14:00

MARGINAL STRUCTURAL MODEL FOR STUDYING THE CAUSAL EFFECT BETWEEN VASO-OCCLUSIVE CRISES AND OCCURRENCE OF DEATH OR COMPLICATIONS IN THE SICKLE-CELL DISEASE PATIENTS
Authors Herquelot, E., Morgan, G., Lamarsalle, L., Raguideau, F., Burke, T., Brown, S., Bonner, A., Bailey, M., Disher, T., Abioye, A.
Poster # PSY38, PL W24 –
PDH 10:30-14:00, ADH 13:00-14:00


RESEARCH POSTER SESSION 2 – MONDAY NOVEMBER 4

ASSESSMENT OF THE SURVIVAL BENEFIT AND COST IMPACT OF NEW TREATMENTS FOR KEY ANSCLC BIOMARKERS USING THE ITEN MODEL
Authors Grima D, Moldaver D, Hurry M
Poster # PCN114, PL G5 – 
PDH 15:30-19:00, ADH 18:00-19:00

COST-EFFECTIVENESS OF SECOND-LINE NILOTINIB VERSUS DASATINIB FOR THE TREATMENT OF PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOID LEUKEMIA-CHRONIC
Authors Maheshwari, V., Tran, D., Agostoni, G., Filioussi, K., Viana, R.
Poster # PCN176, PL T18, 
PDH 15:30-19:00, ADH 18:00-19:00


RESEARCH POSTER SESSION 3 – TUESDAY NOVEMBER 5

A Landscape Assessment of Cell and Gene Therapy Reimbursement in the United States
Authors Hodgson, J., Zec, H., Bedell, W., Burrell A.
Poster # PB14, PL A4 – PDH 10:30-14:00, ADH 13:00-14:00

ICER is Becoming Increasingly Important as a Price Benchmark in the United States
Authors Stino M., Burrell A.
Poster # PB15, PL A5 –
PDH 10:30-14:00, ADH 13:00-14:00

COMPARISON OF A NEW FIBRIN SEALANT TO CURRENT HEMOSTASIS METHODS IN PERIPHERAL VASCULAR SURGERY: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
Authors Danker III W, Ferko N, Garcia D, Hogan A
Poster # PBI2, PL C11 –
PDH 10:30-14:00, ADH 13:00-14:00

A COST ANALYSIS OF HEMOSTATIC SURGICAL RESOURCES ASSOCIATED WITH A NOVEL FIBRIN SEALANT COMPARED TO STANDARD OF CARE ACROSS SURGERY TYPES
Authors Danker III W, Ferko N, Hogan A
Poster # PBI23
, PL C11 – PDH 10:30-14:00, ADH 13:00-14:00

ECONOMIC ANALYSIS OF WOUND CLOSURE METHODS IN KNEE ARTHROPLASTY FROM 4 EUROPEAN COUNTRIES
Authors Jamous N, Hogan A, Ferko N, Chen B, Paragò V, Piemontese A, Michnacs K, Schroer D, Bourras P
Poster # PMS63, PL T24 – 
PDH 10:30-14:00, ADH 13:00-14:00

THE ECONOMIC IMPACT OF TRICLOSAN-COATED SUTURES IN WOUND CLOSURE: A BUDGET IMPACT ANALYSIS FROM HOSPITAL PERSPECTIVE IN ITALY
Authors Piemontese A, Jamous N, Hogan A, Wright G, Paragò V
Poster # PIN21, PL M3 – 
PDH 10:30-14:00, ADH 13:00-14:00

LONG-TERM ASSOCIATION OF OBSERVED VERSUS PREDICTED MICRO- AND MACROVASCULAR COMPLICATIONS IN TYPE 1 DIABETES MELLITUS- EXTERNAL VALIDATION OF THE CORNERSTONE DIABETES SIMULATION MODEL (CDSM)

Authors Moldaver, D., Bartelt-Hofer, J., Afonso, M., Ainslie-Garcia, M., Sauriol, L., Grima, D.
Poster # PDB6, PL F15 – 
PDH 10:30-14:00, ADH 13:00-14:00


RESEARCH POSTER SESSION 4 – TUESDAY NOVEMBER 5

AN ECONOMIC ANALYSIS OF ENDOVASCULAR ARTERIOVENOUS FISTULAS IN DIALYSIS PATIENTS: A US AND PROVIDER PERSPECTIVE
Authors Chen D, Barclay B, Druchok C, Ferko N
Poster # PCV27, PL C15 –
PDH 15:30-19:00, ADH 18:00-19:00

Budget Impact of a Dual-layer Stent Retriever (DLSR) In the Treatment of Patients with Acute Ischemic Stroke (AIS) from Hospital’s Perspective in France and Sweden (EMEA)
Authors Ehm A, Crivera C, Qadeer R, Cameron H
Poster # PCV46, PL D10 – 
PDH 15:30-19:00, ADH 18:00-19:00

Budget Impact Analysis of a Dual-Layer Stent Retriever for the Treatment of Large Vessel Strokes: A U.S. Payer Perspective
Authors Ehm A, Crivera C, Qadeer R, Cameron H
Poster # PCV43, PL D7 –
PDH 15:30-19:00, ADH 18:00-19:00


RESEARCH POSTER SESSION 5 – WEDNESDAY NOVEMBER 6

A BUDGET IMPACT MODEL FOR MEDICATION REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE PATIENTS TREATED WITH LAPAROSCOPIC NISSEN FUNDOPLICATION OR MAGNETIC SPHINCTER AUGMENTATION: AN ITALIAN PAYER PERSPECTIVE
Authors Julia Weickum, Ailish Gonzalez, George Wright, Rana Qadeer, Nicole Ferko
Poster # PGI11, PL B5 –
PDH 9:30-14:00, ADH 12:45-13:45


Schedule a meeting with one of our experts.